Harvard Bioscience

NASDAQ:HBIO  
2.08
-0.02 (-0.95%)

People also watch

StockTwits Share  Twitter Share  Facebook Share
Market Cap (Intraday)77.61M
Current PEN/A
Forward PE 10.95
2yr Forward PE 7.7
See more stats...
Estimates Current Quarter
Revenue$30.26 Million
Adjusted EPS$0.05
See more estimates...
10-Day MA$2.09
50-Day MA$3.00
200-Day MA$3.78
See more pivots...

HARVARD BIOSCIENCE INC Stock, NASDAQ:HBIO

84 OCTOBER HILL RD, HOLLISTON, MA 01746
United States of America
Phone: 5088938999
Number of Employees: 411

Description

Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science basic research, drug discovery, and clinical and environmental testing. The company offers cell and animal physiology products, such as syringe pump and peristaltic pump products, as well as a range of instruments and accessories, including surgical products, infusion systems, microdialysis instruments, behavior research systems, and isolated organ and tissue bath systems, as well as in vivo and in vitro electrophysiology recording, stimulation, and analysis systems for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, Hugo-Sachs, InBreath Bioreactor, MCS, TBSI, and HEKA brands. It also provides products for molecular biology labs comprising pipettes and pipette tips, gloves, gel electrophoresis equipment and reagents, autoradiography films, thermal cycler accessories and reagents, sample preparation columns, tissue culture products, and general lab equipment and consumables under the Denville Scientific and other brands. In addition, the company offers spectrophotometers under the Libra, WPA, and BioDrop brands; microplate readers; amino acid analyzers; gel electrophoresis equipment under the Hoefer and Scie-Plas brands; and electroporation and electrofusion products, including systems and generators, electrodes, and accessories for research applications, such as in vivo, as well as in vitro gene delivery, cell fusion, and nuclear transfer cloning under the Harvard Apparatus BTX brand. Harvard Bioscience, Inc. markets its products to research scientists at universities, hospitals, government laboratories, and pharmaceutical and biotechnology companies. The company sells its products in approximately 100 countries through sales organization, Websites, catalogs, and distributors. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.